Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib mesylate in MPNST
NCT00427583Phase 3Terminated
- Sponsor
- Novartis
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imatinib in malignant peripheral nerve sheath tumor (MPNST), sponsored by Novartis. Started May 2006; status: terminated.
02
Drugs
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT00427583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427583.